FBONX | JABLX | FBONX / JABLX | |
Total Expense Ratio | 0.30 | 0.62 | 48% |
Annual Report Gross Expense Ratio | 0.30 | 0.62 | 48% |
Fund Existence | 5 years | 32 years | - |
Gain YTD | 4.568 | 0.763 | 599% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 244B | 8.97B | 2,719% |
Annual Yield % from dividends | 2.18 | 1.96 | 111% |
Returns for 1 year | 5.58 | 5.46 | 102% |
Returns for 3 years | 34.82 | 33.77 | 103% |
Returns for 5 years | N/A | 47.24 | - |
Returns for 10 years | N/A | 92.29 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETNHX | 32.96 | -0.23 | -0.69% |
Eventide Healthcare & Life Sciences N | |||
PIGDX | 16.26 | -0.16 | -0.97% |
Federated Hermes International Growth IS | |||
AFICX | 83.75 | -0.93 | -1.10% |
American Funds Fundamental Invs C | |||
JAWWX | 117.22 | -1.52 | -1.28% |
Janus Henderson Global Research T | |||
HFAHX | 15.13 | -0.21 | -1.37% |
Hartford Schroders Intl Cntrrn Val Y |